1-4 of 4
Adnan Mansoor, MD, FCPS, FRCP(C), FCAP
Close
Sort by
Journal Articles

A miRNA Risk Score for the Prediction of Response to Lenalidomide in Multiple Myeloma (MM) Patients

Paola Neri, MD, PhD, Andrew R Belch, MD, Jordan Johnson, Kathy J Gratton, Li Ren, PhD, Peter Duggan, MD, FRCPC, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Douglas A. Stewart, MD, FRCP, Nizar Bahlis, MD
Journal: Blood
Blood (2011) 118 (21): 987.
https://doi.org/10.1182/blood.V118.21.987.987
Published: 2011
Journal Articles

Bortezomib Induced BRCAness Sensitizes Multiple Myeloma Cells to PARP Inhibitors

Paola Neri, MD, PhD, Li Ren, PhD, Kathy Gratton, Erin Stebner, Carolyn J Owen, MD, FRCPC, Peter Duggan, MD, FRCPC, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Douglas A. Stewart, MD, FRCP, Nizar J Bahlis, MD
Journal: Blood
Blood (2010) 116 (21): 789.
https://doi.org/10.1182/blood.V116.21.789.789
Published: 2010
Journal Articles

A miRNA Risk Score for the Prediction of Response to Rituximab-CHOP Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma

Nizar J Bahlis, MD, Carolyn J Owen, MD, FRCPC, Paola Neri, MD, PhD, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Kathy J Gratton, Peter Duggan, MD, FRCPC, Pietro Ravani, MD, PhD, Douglas A. Stewart, MD, FRCP
Journal: Blood
Blood (2010) 116 (21): 324.
https://doi.org/10.1182/blood.V116.21.324.324
Published: 2010
Journal Articles

High Herpesvirus-Specific T Cell Counts Are Associated with near-Zero Likelihood of Malignancy Relapse and a Low Likelihood of Infections Due to Any pathogen.

Mette Hoegh-Petersen, MD, Sarah Sy, Alejandra Ugarte-Torres, Tyler S Williamson, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Yiping Liu, Stephanie Liu, Kevin Fonseca, Faisal Khan, James A Russell, Jan Storek, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1285.
https://doi.org/10.1182/blood.V116.21.1285.1285
Published: 2010